US Medical Communications Manager - Cardiovascular/Bone TA

We are building upon our solid oncology foundation and long-term commitment to patients by developing a whole new class of novel molecules - and we need top talent to ensure these molecules become medicines and realize their potential for helping patients.

Amgen is searching for a US Medical Communications Manager in our Cardiovascular & Bone therapeutic area. This manager will report to our Director of Medical Communications and will work out of our Thousand Oaks, CA corporate campus.

The US Medical Communications Manager is responsible for developing high quality, scientifically rigorous resources that adhere to internal guidelines, SOPs, policies and industry regulations.

This includes:

• Reviewing field-based promotional and educational materials for scientific accuracy as part of the Material Approval and Compliance (MAC)
• Responding to escalations from the US call center to help address external customer questions regarding Amgen products and pipeline molecules
• Developing de novo US Core Content to be used in regional medical communications and/or regionalizing global GCC resources for Medical Information and Regional Medical Liaisons
• Executing regional congress deliverables, disease state education programs and developing/adapting scientific content for online resources (e.g. websites, microsites, virtual congresses)
• Collaborating in a dynamic environment with multiple global and regional cross-functional teams
• Managing external providers and project-associated budgets.

This manager can expect up to 10% domestic travel.

Basic Qualifications:

Doctorate degree

OR

Master's degree and 3 years of clinical, academic, or industry experience

OR

Bachelor's degree and 5 years of clinical, academic, or industry experience

OR

Associate's degree and 10 years of clinical, academic, or industry experience

OR

High school diploma / GED and 12 years of clinical, academic, or industry experience

Preferred Qualifications:

• Doctorate degree (PharmD, PhD, MD, DO) with one or more years of cumulative experience in Medical/Scientific Affairs, Clinical Development, Clinical Research, patient care, and/or basic research
• Prior experience in Medical Affairs or Clinical Development within the biopharmaceutical industry (or clinical experience) in the Bone or Cardiovascular disease area
• Understanding of Scientific Communications projects including disease state education programs, advisory boards, congress/publication plans, and RML resources
• Understanding of Medical Information capabilities, literature surveillance, adverse event and product complaints requirements
• Experience with marketed products and late-stage pipeline products
• Excellent written, oral, and presentation skills and the ability to critically analyze the scientific literature to form logical opinions and communicate key business and clinical information at multiple levels
• An understanding of the pharmaceutical commercialization process and knowledge of the legal and regulatory guidelines affecting promotion of prescription products
• The ability to work in teams and interface in a dynamic environment across corporate functions
• Prior experience managing consultants and vendors

We understand that to successfully sustain and grow as a global enterprise and deliver for patients - we must ensure a diverse and inclusive work environment.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

#LI-POST